Europe Animal Health Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals, Diagnostics, Equipment & Disposables, Medicinal Feed Additives), By Animal, By Country, And Segment Forecasts, 2025 - 2033
Description
Europe Animal Health Market Summary
The Europe animal health market size was estimated at USD 16.56 billion in 2024 and is projected to reach USD 34.84 billion by 2033, growing at a CAGR of 8.64% from 2025 to 2033. The industry is experiencing growth driven by the rising prevalence of zoonotic and infectious diseases, growth of the companion animal population and pet humanization,advancements in veterinary pharmaceuticals and biologics, and regulatory support and food safety standards.
Increasing outbreaks of zoonotic and infectious diseases have raised concerns across Europe’s livestock and companion animal sectors. According to the French Agricultural Research Centre for International Development CIRAD, France has faced bluetongue virus (BTV) and epizootic hemorrhagic disease (EHD) outbreaks in 2023, with a new BTV strain spreading across Europe in 2024. This growing disease burden drives demand for advanced vaccines, diagnostics, and preventive solutions to ensure biosecurity and herd protection. This leads to greater investment in veterinary pharmaceuticals, surveillance systems, and R&D initiatives. Thus, companies and governments are prioritizing disease control strategies, strengthening the animal health market across Europe.
The rising pet ownership has increased demand for sophisticated veterinary treatment throughout Europe, strengthened by cultural movements toward pet humanization. Pet owners see their pets as part of the family rather than as possessions, thus increasing their expenditure on high-quality food, health programs, and preventative care. According to the Animal Health Europe report, the region places a high priority on caring for companion animals, as evidenced by the 28 billion euros spent on pet food, 25 billion on pet-related goods and services, and 4 billion on animal medications. Increased use of parasiticides, veterinary medications, diagnostic testing, and wellness products is fueled by this trend. Access to high-quality treatment is further supported by the prevalence of pet insurance in countries like the UK, Sweden, and Germany. As a result, the companion animal health sector is becoming one of the most dynamic growth areas, boosting overall market expansion.
Continuous R&D investment in veterinary pharmaceuticals, vaccines, and biologics has enhanced treatment and prevention options for both livestock and companion animals. Disease management is changing as a result of innovations, including next-generation vaccinations, long-acting injectables, and monoclonal antibodies. As per the report of Animal Health Europe, the animal medicines industry invested over USD 649 million in R&D in 2024. Similarly, in 2024, the European Medicines Agency authorized 25 new animal health products for veterinary use. These advancements improve treatment efficacy, reduce resistance issues, and expand preventive healthcare adoption. Companies introducing innovative therapies gain a strong competitive advantage, improving overall herd and pet health outcomes. This accelerates demand for biologics and pharmaceutical products, increasing steady revenue growth and strengthening the innovation pipeline in Europe’s animal health industry.
The European Union upholds stringent laws pertaining to food safety, antimicrobial use, and animal welfare to safeguard both customers and animals. Industry methods have changed as a result of initiatives like the EU's ban on regular antibiotic growth promoters and emphasis on sustainability. These regulations promote the use of probiotics, vaccinations, and sophisticated diagnostics in place of antibiotics. Furthermore, the manufacturers are encouraged to invest in advanced technologies that adhere to the strict safety and efficacy standards of the EU. This regulatory framework supports the long-term growth of the animal health industry in Europe, boosts market expansion, and increases public confidence in the food supply chain.
Europe Animal Health Market Report Segmentation
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Europe animal health market report based on product, animal and country.
The Europe animal health market size was estimated at USD 16.56 billion in 2024 and is projected to reach USD 34.84 billion by 2033, growing at a CAGR of 8.64% from 2025 to 2033. The industry is experiencing growth driven by the rising prevalence of zoonotic and infectious diseases, growth of the companion animal population and pet humanization,advancements in veterinary pharmaceuticals and biologics, and regulatory support and food safety standards.
Increasing outbreaks of zoonotic and infectious diseases have raised concerns across Europe’s livestock and companion animal sectors. According to the French Agricultural Research Centre for International Development CIRAD, France has faced bluetongue virus (BTV) and epizootic hemorrhagic disease (EHD) outbreaks in 2023, with a new BTV strain spreading across Europe in 2024. This growing disease burden drives demand for advanced vaccines, diagnostics, and preventive solutions to ensure biosecurity and herd protection. This leads to greater investment in veterinary pharmaceuticals, surveillance systems, and R&D initiatives. Thus, companies and governments are prioritizing disease control strategies, strengthening the animal health market across Europe.
The rising pet ownership has increased demand for sophisticated veterinary treatment throughout Europe, strengthened by cultural movements toward pet humanization. Pet owners see their pets as part of the family rather than as possessions, thus increasing their expenditure on high-quality food, health programs, and preventative care. According to the Animal Health Europe report, the region places a high priority on caring for companion animals, as evidenced by the 28 billion euros spent on pet food, 25 billion on pet-related goods and services, and 4 billion on animal medications. Increased use of parasiticides, veterinary medications, diagnostic testing, and wellness products is fueled by this trend. Access to high-quality treatment is further supported by the prevalence of pet insurance in countries like the UK, Sweden, and Germany. As a result, the companion animal health sector is becoming one of the most dynamic growth areas, boosting overall market expansion.
Continuous R&D investment in veterinary pharmaceuticals, vaccines, and biologics has enhanced treatment and prevention options for both livestock and companion animals. Disease management is changing as a result of innovations, including next-generation vaccinations, long-acting injectables, and monoclonal antibodies. As per the report of Animal Health Europe, the animal medicines industry invested over USD 649 million in R&D in 2024. Similarly, in 2024, the European Medicines Agency authorized 25 new animal health products for veterinary use. These advancements improve treatment efficacy, reduce resistance issues, and expand preventive healthcare adoption. Companies introducing innovative therapies gain a strong competitive advantage, improving overall herd and pet health outcomes. This accelerates demand for biologics and pharmaceutical products, increasing steady revenue growth and strengthening the innovation pipeline in Europe’s animal health industry.
The European Union upholds stringent laws pertaining to food safety, antimicrobial use, and animal welfare to safeguard both customers and animals. Industry methods have changed as a result of initiatives like the EU's ban on regular antibiotic growth promoters and emphasis on sustainability. These regulations promote the use of probiotics, vaccinations, and sophisticated diagnostics in place of antibiotics. Furthermore, the manufacturers are encouraged to invest in advanced technologies that adhere to the strict safety and efficacy standards of the EU. This regulatory framework supports the long-term growth of the animal health industry in Europe, boosts market expansion, and increases public confidence in the food supply chain.
Europe Animal Health Market Report Segmentation
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Europe animal health market report based on product, animal and country.
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Animal Outlook (Revenue, USD Million, 2021 - 2033)
- Production Animal
- Poultry
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Swine
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Cattle
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Sheep & Goat
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Fish
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Companion Animal
- Dogs
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Cats
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Horses
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Pet Birds
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Other Companion Animals
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Country Outlook (Revenue, USD Million, 2021 - 2033)
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Norway
- Denmark
- Netherlands
- Russia
- Switzerland
- Ireland
- Poland
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Animal
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR’s Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.5. Information/Data Analysis
- 1.5.1. Data Analysis Models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Model 1 Analysis
- 1.7.2. Model 2 Analysis
- 1.7.3. Model 3 Analysis
- 1.8. List of Secondary Sources
- 1.9. List Of Abbreviations
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Market Variable Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary/Related Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising Prevalence Of Zoonotic And Infectious Diseases
- 3.2.1.2. Growth Of The Companion Animal Population And Pet Humanization
- 3.2.1.3. Advancements In Veterinary Pharmaceuticals And Biologics
- 3.2.1.4. Regulatory Support And Food Safety Standards
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High Cost Of Advanced Healthcare Solutions
- 3.2.2.2. Limited Access To Veterinary Care
- 3.2.2.3. Complex regulations
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Technology Landscape
- 3.4. Pricing Model Analysis
- 3.5. Estimated Animal Population by key Animal & by key Country, 2024
- 3.6. Market Analysis Tools
- 3.6.1. Porter’s Five Forces Analysis
- 3.6.2. PESTEL By SWOT Analysis
- Chapter 4. Europe Animal Health Market: Animal Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Europe Animal Health Market: Animal Movement Analysis
- 4.3. Europe Animal Health Market Size & Trend Analysis, by Animal, 2021 to 2033 (USD Million)
- 4.4. Production Animal
- 4.4.1. Production Animal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Poultry
- 4.5.1. Poultry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2. Biologics
- 4.5.2.1. Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2.2. Vaccines
- 4.5.2.2.1. Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2.2.2. Modified/ Attenuated Live
- 4.5.2.2.2.1. Modified/ Attenuated Live Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2.2.3. Inactivated (Killed)
- 4.5.2.2.3.1. Inactivated (Killed) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2.2.4. Other Vaccines
- 4.5.2.2.4.1. Other Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2.3. Other Biologics
- 4.5.2.3.1. Other Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
